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It is now clear that the epidermis has an active role in
local immune responses in the skin. Keratinocytes are
involved early in inflammation by providing first-line
innate mechanisms and, in addition, can contribute to
adaptive immune responses that may be associated
with clinical disease. Moreover, keratinocytes are
capable of enhancing and shaping the outcome of
inflammation in response to stimuli and promoting
particular types of immune bias. Through under-
standing the underlying mechanisms, the role of
keratinocytes in disease pathogenesis will be further
defined, which is likely to lead to the identification of
potential targets for prophylactic or therapeutic
intervention.
Journal of Investigative Dermatology (2012) 132, 940–948; doi:10.1038/
jid.2011.398; published online 5 January 2012
INNATE RECOGNITION MECHANISMS OF
KERATINOCYTES (KCs)
The epidermis provides a structural barrier for many
external challenges, yet is also able to provide active signals
related to barrier compromise and distinguish different types
of challenges. Through these mechanisms, KCs can signi-
ficantly influence the resultant innate and adaptive immune
responses. For example, KCs are known to express Fc
receptors such as FcgRI, FcgRII, and FcgRIII (Tigalonowa
et al., 1990; Cauza et al., 2002), as well as complement
receptors, mannose receptor (Szolnoky et al., 2001), and
other molecules that potentially aid internalization such as
a5b1 fibronectin–binding integrin (Pellegrini et al., 1992).
Binding to these results in effective endocytosis and subse-
quent killing of bacteria, fungi, and viruses, as documented
for a variety of pathogens, including Staphylococcus aureus
(Kisich et al., 2007), Candida albicans (Csato et al., 1986;
Szolnoky et al., 2001), and Herpes simplex virus (Nicola
et al., 2005). In addition, KCs express a spectrum of
innate recognition receptors that can screen the external
environment and provide proinflammatory and chemotactic
signals to immune cells in a case of pathogen invasion.
Various studies have reported that KCs also express Toll-
like receptors (TLRs) 1–6 and 10 (Baker et al., 2003; Mempel
et al., 2003; Pivarcsi et al., 2003, 2004; Flacher et al., 2006;
Lebre et al., 2007; de Koning et al., 2010), as well as TLR4-
associated CD14 and MD-2 proteins (Kollisch et al., 2005) in
culture and in the skin. In addition, some studies also showed
the presence of TLR7, 8, and 9 (Mempel et al., 2003; Miller
et al., 2005; Flacher et al., 2006; Lebre et al., 2007) in these
cells. Moreover, TLR expression can be further upregulated
by certain pathogens, e.g., Mycobacteria (Pivarcsi et al.,
2003; Lee et al., 2009), Malassezzia (Baroni et al., 2006),
Propionibacterium (Jugeau et al., 2005), viral stimulation
(Lebre et al., 2003; Kalali et al., 2008), and various pathogen-
derived products (Pivarcsi et al., 2003; Kobayashi et al.,
2009). Cytokines such as transforming growth factor-a and
IFN-a (Miller et al., 2005; Prens et al., 2008) also enhance
TLR levels in KCs in vitro. In agreement with this, increased
expression of certain TLRs has been observed in inflammatory
and infectious skin diseases such as psoriasis, acne, atopic
eczema, and Varicella–Zoster virus infection (Baker et al.,
2003; Lai and Gallo, 2008).
In addition to the TLRs, it has been recently documented
that KCs express other receptors that recognize conserved
molecular patterns, e.g., NOD-like receptors. Both NOD 1
and 2 seem to be constitutively present in these cells (Harder
and Nunez, 2009; Kobayashi et al., 2009). NOD1 can be
further upregulated under stimulation with cytokines, espe-
cially IFN-g (Harder and Nunez, 2009). Relevance of the
pathway was additionally demonstrated by detection of IL-8
release from KCs during the response to infection with
NOD1-activating bacteria, Pseudomonas aeruginosa (Harder
and Nunez, 2009). Expression and function of NOD2
receptor in the epidermis was investigated in the context of
antimicrobial function by Voss et al. (2006). This study
demonstrated that the activation of the NOD2 pathway
results in HBD-2 production (Voss et al., 2006). On the basis
of a murine model, Kim et al. (2008) suggested that
transforming growth factor–activated kinase 1 is an essential
signaling molecule in the NOD2 pathway and important for
maintenance of epidermal homeostasis (Omori et al., 2006).
C-type lectins comprise another group of conserved
pattern receptors that may have a role in epidermal
recognition of microbes. In the steady state, KCs express
low levels or appear negative for the expression of the best-
characterized member of this group, dectin-1 (Lee et al.,
2009; de Koning et al., 2010). However, the expression of
dectin-1 is inducible in KCs on exposure to bacteria and the
receptor aids pathogen internalization, as demonstrated in
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Mycobacterium ulcerans infection (Kobayashi et al., 2009).
The same study reported that the stimulation by b-glucan
itself can also upregulate its own receptor (Kobayashi et al.,
2009), which suggests a possibility that dectin-1 could be
induced upon exposure to various fungal species.
Very recently, KCs were also tested for the expression of
members of the family of RIG-like helicase receptors that are
able to detect viral single-stranded RNA and double-stranded
RNA (Kalali et al., 2008). Kalali et al. (2008) demonstrated
that human KCs constitutively express low levels of RIG-I,
MDA-5, and protein kinase R and that these virus-sensing
receptors can be upregulated by several-fold following
exposure to poly I:C. The authors also highlighted the
importance of protein kinase R as a central antiviral
mechanism for double-stranded RNA stimulation, controlling
a broad spectrum of pathways activated during viral invasion
(Kalali et al., 2008). Inflammatory conditions are also likely
to influence the recognition of double-stranded RNA by
RIG-like helicase receptors in KCs, as demonstrated under
IFN-g stimulation (Prens et al., 2008). Enhanced expression of
molecules belonging to this group of pattern recognition
receptors has been reported in various skin conditions (Prens
et al., 2008; Zahn et al., 2011), which suggests relevance to
the inflammatory state. In agreement with this, upregulation
of the receptors under IFN-a/g stimulation in the in vitro
model of psoriasis has been reported (Racz et al., 2011).
Interestingly, this overexpression was demonstrated to
diminish under UVB exposure (Racz et al., 2011), known to
dampen the inflammation in psoriatic patients. Finally, the
notion of RNF114, recently reported as a novel target gene in
psoriasis by genome-wide association studies (Capon et al.,
2008), as a regulator of RIG-I/MDA5 signaling in KCs,
suggests that these viral sensors are key mediators during
epithelial autoimmune inflammation (Bijlmakers et al.,
2011).
As shown above, considerable evidence points to the role
of KCs in early detection of pathogens characterized by the
presence of conserved molecular patterns, such as viral
nucleic acids, lipopolysaccharide, flagellin, and zymosan,
and so on. Sensing incoming threats enables the epidermis to
react as the first line of response that involves, depending on
the agonist, induction of chemotactic mediators, such as IL-8,
CCL2, CCL20, CCL27, CXCL16, CXCL9, and CXCL10
(Pivarcsi et al., 2003; Kollisch et al., 2005; Miller et al.,
2005; Lebre et al., 2007; Tohyama et al., 2007; Lee et al.,
2009; Niebuhr et al., 2010). In addition, proinflammatory
tumor necrosis factor (TNF)-a, type I IFN, IL-1a, IL-6, IL-18,
defensins, cathelicidin (LL-37), and thymic stromal lympho-
poietin (TSLP) secretion can be also observed (Lebre et al.,
2007; Prens et al., 2008; Kinoshita et al., 2009; Kobayashi
et al., 2009). These key mediators help promote recruitment
of neutrophils, monocytes, dendritic cells (DCs), and various
subsets of lymphocytes to the epidermis.
Several studies have observed links between pathways of
innate systems of microbial recognition in KCs. For example,
dectin-1 expression can be modulated by TLR2 stimulation
(Kobayashi et al., 2009; Lee et al., 2009). Moreover, very
recently, Muller-Anstett et al. (2010) have also reported that
Staphylococcal peptidoglycan is able to stimulate both NOD-
2 and TLR2 receptor in mice. These examples indicate that
there is a degree of cross-talk between innate pathways in
KCs. It has also been reported that levels of TLR2, NOD-2,
and dectin-1 are amplified by histamine stimulation (Kobaya-
shi et al., 2009). This synergism between pattern recognition
receptors and histamine suggests that there could be positive
feedback between mechanisms of innate immunity and
inflammation, especially during allergic-type responses in
the skin. This could potentially result in an increased
reactivity to pathogens, e.g., in the skin of atopic individuals.
Finally, very intriguing data come from the recent study of
Trompette et al. (2009), who revealed that apart from
structural mimicry between MD-2 molecules and house dust
mite antigen Der p2 (Derewenda et al., 2002; Kim et al.,
2007; Ohto et al., 2007), there is also a strong functional
similarity, resulting in nonspecific adjuvant-like effect of the
antigen via innate immune pathways.
Taken together, it is clear that KCs are well equipped in
mechanisms that support detection of conserved molecules,
which can be enhanced further as the cells encounter
pathogens. Activation of these pathways results in cytokine
and chemokine release, independent from epidermal or
dermal immune cells. Moreover, any further interactions
between the innate pathways of microbial recognition are
likely to additionally enhance the induction of proinflamma-
tory factors, which further supports adjuvant-like properties of
the epidermis. This suggests that KCs have an important role
during the innate phase of immune responses to invading
pathogens as they react by an early wave of chemokine and
cytokine release and attract key effector immune cells.
DIRECT ACTIVATION OF ANTIGEN-SPECIFIC T CELLS
Various studies documented that KCs do not normally express
the co-stimulatory molecules CD80/86 (Black et al., 2007),
and thus they are unlikely to prime naı¨ve T cells in a steady
state (Gaspari et al., 1988; Otten et al., 1996; Laning et al.,
1997). Consistently, early reports have indicated that class-
II–mediated presentation of antigen by KCs results in
tolerance or anergy of T cells (Gaspari et al., 1988; Bal
et al., 1990). However, the upregulation of molecules
involved in the stimulation of T cells by KCs has been
observed in multiple human skin diseases, which implies that
during inflammatory states, KCs may be able to stimulate
antigen-experienced T cells. However, most authors agree
that they are unlikely to be able to prime new T-cell
responses, a characteristic of conventional antigen-presenting
cells (APCs) such as DCs.
Specifically, it has been demonstrated that under certain
inflammatory conditions, KCs can upregulate both major
histocompatibility complex class I and II molecules (Basham
et al., 1985; Bieber et al., 1989; Banno et al., 2003;
Wittmann et al., 2005; Ardern-Jones et al., 2007), as well
as various molecules required for effective major histocom-
patibility complex peptide loading (Albanesi et al., 1998).
In addition, IL-4 exposure has been described to induce
co-stimulatory molecules (Junghans et al., 1996), whereas
stimulation with IFN-g and, to a lower extent TNF-a,
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promotes ICAM-1 expression (Little et al., 1998; Ardern-Jones
et al., 2007; Black et al., 2007). The upregulation of ICAM-1
has been also observed when KCs were exposed to some
sensitizing agents and oxidative stress (Little et al., 1998).
ICAM-1 seems to be able to provide important co-stimulation
(Gaglia et al., 2000). In agreement with this, KCs pretreated
with IFN-g can efficiently stimulate CD4þ antigen–specific
T cells that have already encountered their cognate anti-
gen (Mutis et al., 1993; Ardern-Jones et al., 2007; Black
et al., 2007).
Interestingly, Goodman et al. (1994) determined differ-
ences in cytokine secretion patterns between T cells
stimulated by IFN-g–exposed KCs or peripheral blood mono-
nuclear cells. These data demonstrated that when KCs are
involved in stimulating T cells, a bias toward differential
T-helper effector function can be observed. Lebre et al. (2007)
reported that TLR stimulation of KCs extends further than the
release of inflammatory mediators and attracting immune cells
to the site of infection. According to this study, TLR ligands,
namely poly I:C, flagellin, and lipopolysaccharide, can
additionally upregulate expression of class I and class II major
histocompatibility complex molecules, along with ICAM-1
and CD40, on KCs (Lebre et al., 2007). This further suggests
the possibility of direct interaction of KCs and T cells during
adaptive phase of immune response to common pathogens.
The mechanisms that allow KCs to directly stimulate
T cells have been investigated in the context of S. aureus
exposure (Strange et al., 1994; Ardern-Jones et al., 2007).
Although only a small percentage of the general population
has been reported to be either colonized or infected by the
bacteria, the prevalence increases to up to 90% in patients
suffering from atopic skin disease (Goh et al., 1997; Chiu
et al., 2009; Gomes et al., 2011). First, Strange et al. (1994)
observed KC-mediated activation of allogeneic T cells in
the presence of IFN-g and staphylo–enterotoxin B that was
reduced by the addition of HLA-DR antibodies. However,
as staphylo–enterotoxin B represents nonspecific superanti-
gen-type reactivity, relevance of this finding to specific
antigen-driven activation was difficult to assess. This problem
has been subsequently resolved by Ardern-Jones et al. (2007).
In this experimental system, KC-mediated presentation of
house dust mite antigen Der p1 to specific CD4þ T cells
significantly increased when the cells were first pretreated
with supernatant of staphylo–enterotoxin B–exposed periph-
eral blood mononuclear cell cultures (Ardern-Jones et al.,
2007). The study showed that soluble factors (particularly
IFN-g), released from immune cells following exposure to the
bacteria, could greatly enhance the T-cell stimulation
capabilities of KCs and result in adaptive immune responses
to unrelated antigens (including allergens). Although this
feature of KCs has only been documented in the context of
S. aureus infection, it is plausible that the exposure to other
species of either commensal or pathogenic flora could result
in a similar switch of antigen-presenting function by KCs. In
addition, it is possible that direct or indirect effects of KCs on
regulatory T-cell induction or function may be important in
influencing the eventual inflammatory milieu, but this has
been relatively understudied (Figure 1).
NONCLASSICAL PRESENTATION BY KCs
Apart from involvement in the classical presentation of
peptides, KCs could also be capable of facilitating non-
classical pathways, such as presentation of glycolipids via
CD1 molecules. The expression of CD1d in normal skin is
largely limited to cells of the upper epidermal layers and hair
follicle (Bonish et al., 2000; Adly et al., 2005; Fishelevich
et al., 2006). However, CD1d is overexpressed (Bonish et al.,
2000; Zhao et al., 2008) and can also be present in lower
strata in psoriatic skin, which seems to correspond to the
observed in vitro effect of IFN-g on its expression (Bonish
et al., 2000). Bonish et al. (2000) have also documented that
CD1d could be induced in normal KCs by mechanical
trauma (tape stripping) and, interestingly, by exposure to
poison ivy. CD1d-expressing cultured KCs are able to
activate natural killer T cells for cytokine release in vitro,
particularly when exposed to IFN-g. This indicates that these
cells are potentially capable of presentation of lipid-derived
ligands, in the context of both infection and autoimmune
inflammation. In contrast, however, despite close proximity,
KCs were not able to directly stimulate natural killer T cells
during allergic contact dermatitis (Gober et al., 2008).
Keratinocytes of the stratified epidermis were also
demonstrated to express CD1a, especially in suprabasal
regions of atopic skin (Bieber et al., 1989; Furue et al., 1992),
but it is not clear whether this represents de novo KC
synthesis or acquisition of CD1a from neighboring Langer-
hans cells. Interestingly, this molecule seems to be a potential
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Figure 1. Direct and indirect effects of keratinocytes on innate and adaptive
immune responses. DC, dendritic cell; LC, Langerhans cell; NK, natural
killer; Treg, T-regulatory cell; TSLP, thymic stromal lymphopoietin.
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skin-homing phenotype (Duhen et al., 2009). Although it has
been shown that this population is able to respond to the
CD1a-mediated presentation by DCs (de Jong et al., 2010),
whether these KCs are also able to activate/prime this
population remains currently unknown.
The expression and functional relevance of stress-induced
HLA-related antigens have not been extensively studied in
the epidermis. Reports showed that MICA is expressed by
human KCs (Zwirner et al., 1998, 1999). In a small study,
Molinero et al. (2003) has documented that the expression of
this molecule is increased in seborrheic dermatitis. Interest-
ingly, the genetic association with MICA locus has been
identified in psoriasis (Zwirner et al., 1998; Romphruk
et al., 2004; Pollock et al., 2011). Although these studies
suggest an involvement of the molecule in inflammatory
process in the skin, the cellular contribution has not yet been
identified.
KCs CAN INDIRECTLY INFLUENCE IMMUNE RESPONSES
Apart from any direct induction of T-cell effector function,
activated KCs seem to be also involved in the generation of
adaptive responses by affecting APCs in the skin. Initial
suggestions that these cells may indeed have a role in the
process came from the study by Pastore et al. (1997), who
documented the promoting influence of KC-derived GM-CSF
on the differentiation of monocytes into DCs and their ability
to stimulate naı¨ve T cells. There are some conflicting data
regarding the effect of house dust mite antigens on the
induction of GM-CSF and IL-8. One study suggested that in
contrast to cells of bronchial epithelium, KCs do not express
these cytokines (Mascia et al., 2002). However, the release of
GM-CSF from KCs has been observed following exposure to
Der p1 and Der f1 antigens (Ogawa et al., 2008).
Activation of pattern recognition pathways due to stimula-
tion with bacterial products results in the induction of
chemokines and cytokines in KCs, as mentioned earlier in
this review. In addition, synthesis of the inflammatory
derivatives of arachidonic acid is also increased (Eberhard
et al., 2002). Exposure of KCs to various Malassezia species
also induces a broad spectrum of mediators, including
proinflammatory, Th2- and Th17-promoting cytokines
(Watanabe et al., 2001; Ishibashi et al., 2006, 2011; Thomas
et al., 2008); the profile of response varies depending on the
species. Interestingly, the direct interaction involving contact
of KCs and fungal cells is required, as Malassezia culture
supernatant did not mediate the effect (Watanabe et al.,
2001). Moreover, the secretion seems to be enhanced if the
yeast is decapsulated (Thomas et al., 2008).
Although IL-1a is constitutively produced by KCs
(Luger et al., 1981; Sauder et al., 1982; Kupper et al., 1986;
Little et al., 1998), it can be further upregulated in response to
colonization with Malassezia or bacterial species: Staphylo-
coccus and Propionibacterium (Walters et al., 1995), as
well as following epidermal barrier disruption (Wood et al.,
1996). Early reports suggested that IL-1a represents the majo-
rity or all of IL-1 activity derived from KCs owing to the
inability of these cells to effectively process pro-IL-1b into
the active form (Kupper et al., 1986; Cooper et al., 1990;
McKenzie et al., 1990; Mizutani et al., 1991). However,
others reported the release of IL-1b form by these cells
(Watanabe et al., 2001). The functional effects of IL-1 in the
skin are broad as many cell types express IL-1 receptors. For
example, murine models imply that IL-1a modulates class II
expression and function of Langerhans’ cells (Lundqvist and
Back, 1990). In addition, overexpression of IL-1a in the epi-
dermis seems to have a significant effect on the recruitment of
immune cells, as well as enhancing both T-cell and antibody
responses to vaccinia virus (Tian et al., 2008). Moreover, it
has been also reported that the epicutaneous sensitization in
animal model of contact hypersensitivity is largely dependent
on this cytokine, which is required for the activation of
contact allergen–specific T cells (Nakae et al., 2001).
Keratinocytes also express TNF-a, which seems to be
further induced by exposure to lipopolysaccharide (Kock
et al., 1990) and UVB (Kock et al., 1990; Schwarz et al.,
1995). Early murine studies by Kimber and Cumberbatch,
(1992) reported the effect of TNF-a on induction of
Langerhans cell migration and their accumulation in the
lymph nodes (Cumberbatch and Kimber, 1995). This was also
confirmed later by Stoitzner et al. (1999) who detected
similar augmentation of the migratory properties in both
Langerhans and dermal DCs. More recently, this cytokine has
been reported to be involved in the generation of immature
Langerhans’ cells from CD34þ precursors (Arrighi et al.,
2003). The role of the cytokine during inflammatory process
in the skin has been well documented (Kristensen et al.,
1993; Ettehadi et al., 1994; Junghans et al., 1998; Kerstan
et al., 2011) and further supported by clinical effectiveness of
the anti-TNF treatment in psoriasis (Leonardi et al., 2003;
Papp et al., 2005; Marble et al., 2007; Tyring et al., 2007; van
de Kerkhof et al., 2008).
In 2003, Lebre et al. (2003) investigated the indirect
influence of KCs on DC maturation and T-cell polarization in
the context of antiviral responses. The study showed that KCs
that sense the presence of viral products are able to induce
DC maturation in a TNF-a/IL-1b–dependent mode (Lebre
et al., 2003). Furthermore, they have also documented that
virally activated KCs acquire the ability to indirectly
influence the function of activated T cells. Specifically, the
presence of type I IFNs and IL-18 in the supernatants from
cultures of double-stranded RNA-stimulated KCs influenced
IL-12p70 secretion from immature DCs, which in turn
induced strong Th1 bias in T cells during their priming
(Lebre et al., 2003).
A study by Soumelis et al. (2002) showed that TSLP exerts
multiple effects on peripheral blood–isolated DCs during their
activation and maturation, as well as promotes their survival.
Specifically, under TSLP stimulation, DCs produced high
levels of CCL17 (TARC) and CCL22 that attract CCR4-
expressing Th2 cells to the site of inflammation. Interestingly,
T cells that were primed by TSLP-stimulated DCs produce a
distinct spectrum of cytokines characterized by Th2 bias
(including IL-13, IL-5 and IL-4) and increased TNF-a levels. In
contrast, this type of stimulation resulted in a reduced release
of Th1/Th1-promoting cytokines: IFN-g, IL-12p70, as well as
IL-1b and the regulatory IL-10 (Soumelis et al., 2002). As the
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authors observed high expression of TSLP in KCs, particularly
in atopic dermatitis, as well as in activated mast cells, these
findings are particularly relevant to the Th2-type responses in
allergic skin inflammation.
Subsequently, additional groups have reported findings that
support the role of KC-derived TSLP as a Th2-promoting
cytokine in the skin. Ito et al. (2005) determined a critical role
of OX40 ligation in the TSLP-mediated instructing of T cells to
become Th2 committed. Subsequently, Wang et al. (2006)
published a study that suggested that TSLP-stimulated blood-
derived DCs are involved in inducing Th2 bias not only during
priming of naı¨ve cells but also during the maintenance phase
of central memory cells and further T-cell polarization. In the
following year, Ebner et al. (2007) brought the context directly
to the skin when they investigated the effects of the cytokine
on freshly isolated Langerhans cells and reported very similar
findings; Langerhans cell survival, proliferation, and matura-
tion were enhanced under the stimulation. In addition, the
profile of secreted cytokines was parallel to those that
Soumelis et al. (2002) observed for the peripheral blood
DCs, which suggests that the effect of TSLP is not limited to a
given antigen-presenting subset in the blood, but that
potentially also APCs in the skin can induce Th2-skewed
polarization of naı¨ve T cells. As an additional finding, Ebner
et al. (2007) also presented direct evidence implying enhan-
ced migratory properties of Langerhans cells under TSLP
stimulation. However, TSLP-mediated impact on innate cells
has also been recognized. The study published by Allakhverdi
et al. (2007) determined its role in direct activation and
induction of proinflammatory and Th2 cytokines, as well as in
the release of chemokines from mast cells.
The magnitude of the adaptive responses in the skin is also
likely to be altered by the milieu that influences KCs. Indeed,
this was shown a few years later by Kinoshita et al. (2009)
who studied the effect of various cytokines on the TLSP
release from KCs following TLR3 stimulation. This study
demonstrated an enhancing effect of IL-4, IL-13, type I IFNs,
and TNF-a, as well as a downregulating influence of IFN-g,
transforming growth factor-b, or IL-17 on the expression and
release of this cytokine. Moreover, the integrity of the
epidermis seems to be an important factor in the induction
of TSLP under TLR3 stimulation as well, as recently docu-
mented by Lee et al. (2011) in a filaggrin knockdown model
of viral infection. These two studies imply an existence of a
positive feedback loop between viral infections and compro-
mised integrity of epidermal barrier on one side and allergic
skin inflammation on the other.
Another epidermis-derived cytokine that seems to influ-
ence antigen-specific adaptive responses is a recently
characterized member of the IL-17 family, IL-25 (IL-17E).
Keratinocytes have been shown to constitutively express IL-
25 transcript and protein (Wang et al., 2007; Corrigan et al.,
2011). It has been documented in animal studies that
stimulation with the cytokine also results in the promotion
of Th2 responses (Fort et al., 2001; Pan et al., 2001;
Angkasekwinai et al., 2007). Recently, it has been proposed
that it is an indirect mechanism and that the cytokine
functions by enhancing the Th2 responses driven by TSLP-
stimulated APCs (Wang et al., 2007), a possible explanation
of the induction of the cytokine bias observed in mice.
Finally, a novel IL-1-like cytokine, the ‘‘alarmin’’ IL-33, has
been detected as a constitutively expressed product present in
KCs (Moussion et al., 2008) and upregulated in atopic and
psoriatic plaques. The cytokine also seems to have similar
functional properties as it seems to promote mainly proin-
flammatory and Th2-type responses from a spectrum of
various cell populations, including antigen-specific–com-
mitted Th2 cells (Schmitz et al., 2005; Smithgall et al.,
2008). Moreover, it promotes survival of mast cells and,
interestingly, their activation independent of IgE cross-linking
(Iikura et al., 2007; Hueber et al., 2011). It is also plausible
that the aforementioned cytokines also directly affect APCs in
the skin, as well as other cells including nuocytes, a novel
population of immune cells that seems to respond to IL-25
and IL-33 stimulation by secretion of Th2 cytokines (Neill
et al., 2010). These possibilities, however, remain to be
formally proven.
Keratinocytes are also capable of directing the response
toward a Th1-type bias, by inducing IFN-g release from T
cells, monocytes and macrophages. For example, IL-18, also
constitutively expressed by KCs of the basal epidermal layer
and upregulated in psoriatic skin possesses this property
(Kohka et al., 1998; Naik et al., 1999). Moreover, the
cytokine has been reported to influence Langerhans cell
migration in mouse models of contact hypersensitivity
(Cumberbatch et al., 2001; Plitz et al., 2003).
Taken together, these findings suggest that KCs are a
potent source of cytokines that target immune cells, leading
to the amplification of local innate and adaptive inflamma-
tory responses.
IMPLICATIONS FOR VACCINE DEVELOPMENT
As discussed above, KCs are not just bystanders, but
immunologically active cells that are able to participate at
various stages of the immune response. In fact, the properties
of the epidermis described above, including an ability to
augment inflammatory state and modify its direction, are
also the properties that are characteristics of adjuvants. This
carries some important implications for the generation of
vaccination strategies, especially regarding the feasibility of
relatively recently proposed transcutaneous immunization.
Differential antigen delivery can significantly influence the
resultant immune response (Estcourt et al., 2005).
Human studies documented that immunogenicity against
enterotoxigenic strains of Escherichia coli (Glenn et al., 2000,
2007; Guerena-Burgueno et al., 2002; Yu et al., 2002; Frech
et al., 2008), flu (Van Kampen et al., 2005), and measles
(Etchart et al., 2007) could be induced by transcutaneous
immunization. In murine models, efficacy has been reported
against tetanus (Shi et al., 2001; Ishii et al., 2008; Matsuo
et al., 2011), diphtheria (Matsuo et al., 2011), Japanese
encephalitis virus (Cheng et al., 2009), adenovirus (Ishii et al.,
2008) and various flu strains (Guebre-Xabier et al., 2004;
Garg et al., 2007; Mkrtichyan et al., 2008).
The efficacy in inducing systemic humoral and cellular
responses has been proven (Guerena-Burgueno et al., 2002;
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Yu et al., 2002; Matsuo et al., 2011). In addition, delivery of
antigens via such a formulation has been shown to enhance
Langerhans cell migration to the draining lymph nodes (Ishii
et al., 2008).
Specific-IgG titers seem to correlate with measured
transepidermal water loss after barrier-disrupting treatment
preceding application of the patch (Glenn et al., 2007).
Although one can argue that this is a result of increased
absorption of active vaccine constituents (antigens, pharma-
ceutical adjuvants) through the epidermis into dermal layer, it
can also be related to the enhanced antigen presentation and
secretory capacity of mechanically stimulated KCs. Guebre-
Xabier et al. (2003) have defined a synergistic role of a
transepidermal patch (used as an immunostimulant) and
subcutaneous injection in mice. This was also reproduced in
a human influenza trial in elderly patients (Frech et al., 2005).
It is difficult to assess how much of the in vivo systemic effect
induced by the patches in the aforementioned studies is due
to the adjuvant role of KCs as compared with other cells of
the skin.
An intriguing study has been also recently published by
Liu et al. (2010). The authors of this work aimed to compare
the immunogenicity of an antigen administered through the
superficially injured skin (skin scarification) with other
commonly used delivery routes. Interestingly, they have
observed superior efficacy of this method of administration in
the induction of both T- and B-cell responses to poxviruses, as
well as in the cutaneous melanoma challenge in mice.
Certainly, as KCs have the ability to potentiate stimulation of
inflammatory pathways, the epidermis could contribute to
the modulation of the observed responses, supporting its
adjuvant role.
In summary, the epidermis is a rich source of cytokines
and chemokines that can influence the innate and adaptive
immune responses. It is clear that KCs can directly interact
with immune cells and indirectly influence function through
effects on cutaneous DCs. The underlying mechanisms will
be important in understanding disease pathogenesis, as well
as informing new approaches for antigen delivery through the
skin for vaccination or therapy.
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